Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications
Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.
Journal: The New England journal of medicine
Published: September 02, 2026
Impact of an oncology urgent care center on preventable emergency department visits: revisiting lessons from a global pandemic to improve quality of care.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: July 02, 2025
Final results of a multicentre pilot study evaluating brentuximab vedotin with cyclophosphamide, doxorubicin, etoposide and prednisone (BV-CHEP) for the treatment of aggressive adult T-cell leukaemia/lymphoma.
Journal: British journal of haematology
Published: March 21, 2025
Erratum: Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 18, 2025
Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 07, 2024
Transdifferentiation of diffuse large B-cell lymphoma to a poorly differentiated neoplasm following CAR T-cell therapy.
Journal: Journal of hematopathology
Published: March 13, 2024
High CD34-positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft-versus-host disease or mortality.
Journal: Transfusion
Published: January 08, 2024
Updated COVID-19 clearance time among patients with cancer in the Delta and Omicron waves.
Journal: Cancer medicine
Published: March 11, 2023
Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study.
Journal: The Lancet. Oncology
Published: June 28, 2021
Vaccination as Immunotherapy in Hematologic Malignancies.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 12, 2021
Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia model.
Journal: Haematologica
Published: May 20, 2020
Last Updated: 09/26/2026